Swasahara Mahakashaya - A Comprehensive Review of its Pharmacological and Therapeutic Potential

Authors

  • Anchu Thomas PG Scholar, Department of Dravyagunavigyana, Govt. Ayurveda College, Thiruvananthapuram, Kerala, India.
  • Raghi R G Assistant Professor, Department of Dravyaguna Vigyana, Government Ayurveda College, Thiruvananthapuram Kerala, India.

DOI:

https://doi.org/10.47070/ijapr.v14i10.4348

Keywords:

Swasa, Swasahara Mahakashaya, Dipana, Pachana, Agni

Abstract

Swasa is an important respiratory disorder in Ayurveda, associated with the disturbance of Vata and Kapha Doṣas and dysfunction of Pranavaha srotas. Impaired Agni, Ama accumulation, and Kapha-induced obstruction are considered important factors contributing to its pathogenesis. Classical Ayurvedic literature describes Swasahara Mahakashaya as a group of ten medicinal plants indicated for managing Swasa. The present review aims to explore its classical references, constituent drugs, Ayurvedic pharmacodynamic properties, reported pharmacological activities, and possible mechanisms of action in respiratory disorders. Relevant Ayurvedic texts and available scientific literature are considered to understand the therapeutic relevance of this formulation. The constituent herbs exhibit diverse properties, including Katu, Tikta, and Kashaya Rasa, along with Laghu, Ruksha, and Tikshna Guṇa and, in several constituents, Ushna Virya. These attributes may contribute to Kapha regulation, Ama digestion, Agni stimulation, and the maintenance of respiratory channel function. Contemporary experimental studies on individual constituent plants have reported activities such as anti-inflammatory, antioxidant, antimicrobial, antitussive, bronchodilatory, and immunomodulatory effects. Such findings offer a scientific basis for further investigating the traditional applications of Swasahara Mahakashaya, although direct evidence for the combined formulation remains limited. This review provides an integrated understanding of its traditional principles and emerging pharmacological evidence, identifies gaps in current research, and highlights priorities for future investigation. Standardized experimental studies and well-designed clinical trials are necessary to establish its efficacy, safety, and clinical applicability in respiratory conditions.

Downloads

Download data is not yet available.

Published

17.11.2026

Issue

Section

Articles

How to Cite

1.
Swasahara Mahakashaya - A Comprehensive Review of its Pharmacological and Therapeutic Potential. Int J Ayu Pharm Res [Internet]. 2026 Nov. 17 [cited 2026 Nov. 18];14(10):189-93. Available from: https://ijapr.in/index.php/ijapr/article/view/4348